SurgoCap Partners LP Mala Gaonkar
New York, NY 11 processed 13Fs on this site, 2023 Q4 to 2026 Q2
- $3.1B
- 13 holdings
- 2026 Q2
- +3.3% QoQ
- Top 5 57.9%
Mala Gaonkar's biggest moves in 2026 Q2 were opening Intel and Argan, adding to Visa and McKesson, trimming Alphabet and Corning, and selling out of Nvidia and Niq Global Intelligence.
AUM over time
Latest book
| TSM, Taiwan Semiconductor | Reduce −18.1% | 908,064 | $477.57 | $434M | −200,009 | +$59M | |
| CRS, Carpenter Technology | Reduce −42.6% | 686,473 | $616.84 | $423M | −510,428 | −$48M | |
| GOOG, Alphabet | Reduce −35.1% | 966,080 | $353.33 | $341M | −522,790 | −$86M | |
| LPLA, LPL Financial | Add +4.2% | 1,063,218 | $281.68 | $299M | +42,379 | −$7.6M | |
| MDLN, Medline | Add +23.2% | 7,487,507 | $39.44 | $295M | +1,412,342 | +$25M | |
| MCK, McKesson | Add +8.1% | 376,870 | $755.60 | $285M | +28,138 | −$17M | |
| INTC, Intel | New | 1,848,315 | $139.63 | $258M | +1,848,315 | +$258M | |
| GLW, Corning | Reduce −7.1% | 797,181 | $255.43 | $204M | −61,334 | +$87M | |
| V, Visa | Add +95.7% | 564,207 | $343.09 | $194M | +275,840 | +$106M | |
| AGX, Argan | New | 149,983 | $798.55 | $120M | +149,983 | +$120M | |
| NU, Nu Holdings | Reduce −18.9% | 8,000,728 | $13.36 | $107M | −1,865,332 | −$35M | |
| ISRG, Intuitive Surgical | Reduce −22.8% | 256,963 | $397.68 | $102M | −76,069 | −$51M | |
| DPC, DPC Holdings | New | 638,725 | $49.06 | $31M | +638,725 | +$31M |
Exits / last held
Gone since 2026 Q1, shown at their last reported size.
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| NVDA, Nvidia | Exit | 0 | $174.40 | $176M | −1,008,073 | −$176M | |
| NIQ, Niq Global Intelligence | Exit | 0 | $11.37 | $67M | −5,858,000 | −$67M | |
| SHOP, Shopify | Exit | 0 | $118.62 | $61M | −515,733 | −$61M | |
| FIG, Figma | Exit | 0 | $21.14 | $39M | −1,867,515 | −$39M |
Filings history
11 periods, with AUM normalized
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 13 | $3.1B | +3.3% | 13F-HR | 8/13/2026 | 000091957426005191 |
| 2026 Q1 | 14 | $3B | −17.1% | 13F-HR | 5/15/2026 | 000091957426003167 |
| 2025 Q4 | 17 | $3.6B | +0.4% | 13F-HR | 2/17/2026 | 000091957426001016 |
| 2025 Q3 | 16 | $3.6B | +35.8% | 13F-HR | 11/13/2025 | 000091957425006748 |
| 2025 Q2 | 13 | $2.6B | +30.8% | 13F-HR | 8/14/2025 | 000091957425004655 |
| 2025 Q1 | 12 | $2B | +4.3% | 13F-HR | 5/15/2025 | 000091957425003084 |
| 2024 Q4 | 12 | $1.9B | −3.1% | 13F-HR | 2/14/2025 | 000091957425001210 |
| 2024 Q3 | 12 | $2B | +17.1% | 13F-HR | 11/14/2024 | 000091957424006446 |
| 2024 Q2 | 13 | $1.7B | −8.2% | 13F-HR | 8/14/2024 | 000091957424004550 |
| 2024 Q1 | 14 | $1.9B | +30.1% | 13F-HR | 5/15/2024 | 000091957424003006 |
| 2023 Q4 | 15 | $1.4B | — | 13F-HR | 2/14/2024 | 000091957424001147 |
About
SurgoCap Partners LP
11 processed 13Fs on this site, 2023 Q4 to 2026 Q2